Does Tymlos Have a Generic Version Available?
Currently, there is no generic version of Tymlos (abaloparatide) available on the market [1].
When Might a Generic Version of Tymlos Become Available?
The availability of generic versions of Tymlos depends on the expiration of its patents and any associated exclusivities. Information regarding specific patent expiration dates for Tymlos can be found on resources like DrugPatentWatch.com [2]. The development and approval process for generics can be lengthy, involving patent challenges and regulatory reviews.
What is Tymlos Used For?
Tymlos is a medication used to treat osteoporosis in postmenopausal women at high risk for fracture [3]. It works by stimulating bone formation [4].
How Does Tymlos Work?
Tymlos is a parathyroid hormone-related peptide (PTHrP) analog. It binds to the PTH1 receptor, which is found on bone cells, and activates pathways that increase bone formation and decrease bone resorption, thereby increasing bone mineral density [4][5].
What are the Risks Associated with Tymlos?
Tymlos carries a boxed warning for osteosarcoma, a rare bone cancer. Animal studies have shown an increased risk, and the drug should not be used in patients with a history of osteosarcoma or Paget's disease of bone, or in those with unexplained elevations of alkaline phosphatase, skeletal metastases, or hyperparathyroidism [3]. Other potential risks include hypercalcemia and the potential for an increased risk of cardiac issues, such as an increased heart rate and QT interval prolongation [3][6].
How is Tymlos Administered?
Tymlos is administered as a subcutaneous injection once daily [3].
Who Manufactures Tymlos?
Tymlos is manufactured by Radius Health, Inc. [1].